Navigation Links
Genmab's Financial Calendar for 2008
Date:1/31/2008

COPENHAGEN, Denmark, January 31 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announces its financial calendar for 2008 as follows:

EVENT DATE

Publication of the Annual Report for 2007 Monday, March 31, 2008

Annual General Meeting 2008 Wednesday, April 23, 2008

Publication of the Interim Report for the Wednesday, May 28, 2008

first quarter 2008

Publication of the Interim Report for the Wednesday, August 27, 2008

first half 2008

Publication of the Interim Report for the Wednesday, October 29, 2008

first nine months 2008

Publication of the financial reports will be after market close on the date of the event.

About Genmab A/S

Genmab is a leading international biotechnology company focused on developing fully human antibody therapeutics for unmet medical needs. Using unique, cutting-edge antibody technology, Genmab's world class discovery and development teams have created and developed an extensive pipeline of products for potential treatment of a variety of diseases including cancer and autoimmune disorders. As Genmab advances towards a commercial future, we remain committed to our primary goal of improving the lives of patients who are in urgent need of new treatment options. For more information on Genmab's products and technology, visit http://www.genmab.com.

This press release contains forward looking statements. The words "believe", "expect", "anticipate", "intend" and "plan" and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with product discovery and development
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Monogram Biosciences Announces Fourth Quarter 2007 Financial Results Conference Call
2. CV Therapeutics to Announce 2007 Fourth Quarter and Year End Financial Results on Tuesday, February 26, 2008
3. Carrington Retains Milkie/Ferguson to Explore Financial Alternatives
4. Cynosure to Announce Fourth-Quarter and Full Year 2007 Financial Results on February 12
5. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
6. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
7. 3SBio Inc. Announces Appointment of Kevin Sow Peng Teo as Chief Financial Officer
8. Cardica Announces Fiscal 2008 Second Quarter Financial Results and Business Progress
9. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2007 Financial Results
10. PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results
11. Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014  David Hardison, Ph.D., vice president of ... has been elected chairman of the board for ... working to establish common protocols around the use ... to electronic health records. Hardison ... with organizations across the research and health care ...
(Date:7/28/2014)...   Propeller Health , the FDA-cleared digital health ... Brad Towle as Senior Vice President, Business ... the company,s sales growth, customer acquisition and program expansion. ... his past role in the development of accountable care ... pivotal time in the industry," said David Van ...
(Date:7/28/2014)... 28, 2014 It’s a hard truth: Nearly ... to further their post-secondary education are failing to obtain a ... this year. And according to an analysis by The ... veteran students’ uninformed choice of college majors, which leads to ... the study: Some 51.7 percent of post-9/11 veterans using ...
(Date:7/28/2014)... 28, 2014  InterMune, Inc. (NASDAQ: ITMN ... quarter 2014 financial results at the close of the ... call and webcast will be hosted by InterMune at ... Interested investors and others may participate in the conference ... conference ID#21728775. A replay of the webcast and teleconference will ...
Breaking Biology Technology:ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium 2ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium 3Propeller Health Hires Brad Towle as Senior Vice President of Business and Client Development 2Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 2Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 3Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 4InterMune to Release Second Quarter Financial Results on August 6 2
... 12 Eurand N.V.,(Nasdaq: EURX ), a ... products based on its proprietary drug,formulation technologies, announced ... in the NASDAQ Biotechnology Index (Nasdaq: NBI ... Executive Officer of Eurand, commented, "We are,delighted to ...
... Pa., Nov. 9 ,Southern Research Institute and ... expanded their joint marketing agreement to allow ... biotechnology and,pharmaceutical markets. Ten months ago, the ... joint marketing agreement to collaborate in,marketing contract ...
... tests at once with minimal patient discomfort, ... announced today the launch of the ComforTen(TM) Multiple ... device features ten,surgical steel 1.2mm lancet tips, which ... is the only 10-test, self-loading,surgical steel testing device ...
Cached Biology Technology:Eurand Added to NASDAQ Biotechnology Index 2Eurand Added to NASDAQ Biotechnology Index 3Southern Research Expands Sales and Marketing Agreement with Absorption Systems to Service European Market 2HollisterStier Offers Comfort With New ComforTen(TM) Multiple Skin Testing Device 2HollisterStier Offers Comfort With New ComforTen(TM) Multiple Skin Testing Device 3
(Date:7/28/2014)... that have seen an increase in so-called "nuisance flooding"--which ... storm drains and compromised infrastructure--are on the East Coast, ... nuisance flooding, caused by rising sea levels, has increased ... percent since the 1960s. , The report, Sea Level ... States, also finds Annapolis and Baltimore, Maryland, lead the ...
(Date:7/28/2014)... He calls himself the bug hunter, but the target ... be found and identified with special methods and instruments. ... State Veterinary Diagnostic Laboratory at Kansas State University, recently ... enterovirus G, which is an important find in the ... cells, but didn,t know what it was," Hause said. ...
(Date:7/28/2014)... that can help advance the genetic engineering of ... has been developed by researchers with the U.S. ... a multi-institutional partnership led by Lawrence Berkeley National ... an assay that enables scientists to identify and ... components in the biosynthesis of plant cell walls. ...
Breaking Biology News(10 mins):NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 2NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 3Researcher using next-generation sequencing to rapidly identify pathogens 2Researcher using next-generation sequencing to rapidly identify pathogens 3How sweet it is 2How sweet it is 3
... Catch an athlete with clear potential early in his ... years including victory in the Tour de France, and ... about what training and dedication can accomplish. , What ... out about Lance Armstrong was that from 1992-1999, the ...
... vaccines for related viruses including dengue fever. A monoclonal ... Nile virus has an intriguing secret: Contrary to scientists' ... attach to host cells. Instead, the antibody somehow stops ... "This was a complete surprise to us, but it ...
... at the University of Florida's McKnight Brain Institute have ... first time duplicates neurogenesis -- the process of generating ... in today's (June 13) Proceedings of the National Academy ... holds the promise of producing a limitless supply of ...
Cached Biology News:Lance Armstrong through a physiological lens: hard training boosts muscle power 8% 2Lance Armstrong through a physiological lens: hard training boosts muscle power 8% 3Lance Armstrong through a physiological lens: hard training boosts muscle power 8% 4Lance Armstrong through a physiological lens: hard training boosts muscle power 8% 5Lance Armstrong through a physiological lens: hard training boosts muscle power 8% 6Secrets to antibody's success against West Nile Virus surprise scientists 2Secrets to antibody's success against West Nile Virus surprise scientists 3Secrets to antibody's success against West Nile Virus surprise scientists 4For first time, brain cells generated in a dish 2For first time, brain cells generated in a dish 3
Lysozyme C (W-20)...
... The Jouan B4i ventilated and BR4i refrigerated multifunction ... low speed operation at a low sound level ... certified for biocontainment. Their AUTO-LOCK rotor exchange system ... ready for use within seconds. Instant ...
... (5-bromo-4-chloro-3-indoyl-beta-D-galactopyranoside) is a chromogenic ... recombinant plasmids. In the ... IPTG, lac + ... whereas recombinant colonies appear ...
... enhanced form of Tobacco Etch Virus (TEV) ... and significantly more stable than native TEV ... specifically recognizes a seven amino acid (Glu-Asn-Leu-Tyr-Phe-Gln-Gly, ... useful for removing affinity tags from fusion ...
Biology Products: